Evidence map›Paper›PMID 18386153›Full record

ArticleInternational urology and nephrology2008

Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Hulya Taskapan, Paul Tam, Victoria Au, Stephen Chow, Jason Fung, Gordon Nagai, Janet Roscoe, Paul Ng, Tabo Sikaneta, Robert Ting and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Observational
  2. Article
  3. A perspective on chronic kidney disease progression.American journal of physiology. Renal physiology · 2017
    Review
  4. Article
  5. Social Determinants of Racial Disparities in CKD.Journal of the American Society of Nephrology : JASN · 2016
    Review
  6. Review
  7. Review
  8. Article
  9. Implications of the CKD-EPI GFR estimation equation in clinical practice.Clinical journal of the American Society of Nephrology : CJASN · 2011
    Article
  10. Article
  11. Article
  12. Home dialysis as a first option: a new paradigm.International urology and nephrology · 2009
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hulya TaskapanNephrology, Scarborough General Hospital Toronto, 78 Corporate Drive 10, Scarborough, Toronto, ON, Canada M1H3GH.
Paul Tam
Victoria Au
Stephen Chow
Jason Fung
Gordon Nagai
Janet Roscoe
Paul Ng
Tabo Sikaneta
Robert Ting
Dimitrios G Oreopoulos
The Scarborough Hospital · CAToronto Western Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe adverse effects arising from late referral to a nephrologist of patients with chronic kidney disease (CKD) are well known. Retrospectively we examined the initial characteristics of patients referred in various stages of CKD to our nephrology division and tried to identify potential baseline factors associated with subsequent changes in estimated glomerular filtration rate (eGFR). PATIENTS AND

methodsBetween September 1997 and June 2006 1,443 patients (909 male, 534 female) with CKD, with eGFRs ranging from 15 to 89 ml/min, were referred to our nephrology division and categorized using the National Kidney Foundation classification for CKD based on eGFR. The slope of eGFR change (ml/min-1/1.73/m2-1/year-1) was determined by linear regression analysis and the patients were divided into five groups: (1) significantly progressive slope (deterioration) (more negative than -5 ml/min/year); (2) mildly progressive slope (>-5 to <or=-1); (3) stable slope (>-1 to <or=+1); (4) mildly improved slope (>+1 to <or=+5), and (5) significantly improved slope (>or=+5).

resultsAt the first nephrology referral, 5.8% of the patients were on CKD stage 2 (eGFR: 90-60 ml/m), 46.7% on CKD stage 3 (eGFR: 59-30 ml/m), and 47.5% on CKD stage 4 (eGFR: 29-15 ml/m) CKD. Significantly improved slope was detected in 48.2% of CKD stage 2 patients, 29.3% of CKD stage 3 patients, and only 14.7% of CKD stage 4 patients (P<0.05). Being in stage 4 or stage 3 versus being in stage 2 significantly reduced the likelihood of an improved slope in logistic regression analysis whereas age, gender, presence of hypertension, and diabetes mellitus did not reach the level of significance.

conclusionReferral to a nephrology clinic can lead not only to arrest of progression of CKD but also to regression/improvement. Early referral is a positive predictive factor for improvement in eGFR, which emphasizes the importance of such referral. The previously held idea that, once established, CKD progresses invariably is not valid anymore.

Indexed as

AgedAnalysis of VarianceFemaleGlomerular Filtration RateHumansKidney Failure, ChronicLogistic ModelsMaleReferral and ConsultationRetrospective Studies

Identifiers

PMID18386153
OpenAlexW2076098785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.